Sick Stopper
- Manufacturer
- Newton Laboratories, Inc.
- Effective date
- 2011-03-01
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:05:03
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
INDICATIONS & USAGE SECTION
Sick Stopper Formulated for symptoms associated with colds and infections. Begin at the onset of symptoms.
DOSAGE & ADMINISTRATION SECTION
Directions: Ages 12 and up, take 6 pellets orally (ages 0 to 11, give 3 pellets) as needed or as directed by a healthcare professional. Under age 2, crush or dissolve pellets in purified water. Sensitive persons begin with 1 pellet and gradually increase to full dose.
OTC - ACTIVE INGREDIENT SECTION
Anthracinum 30x, Influenzinum 30x, Pyrogenium 30x, Bufo rana 15x, Aconitum nap. 10x, Agaricus musc. 10x, Aralia quinquefolia 10x, Baptisia 10x, Bryonia 10x, Chelidonium majus 10x, Eupatorium perf. 10x, Hepar sulph. calc. 10x, Lachesis 10x, Lycopodium 10x, Nux vom. 10x, Rhus toxicodendron 10x, Sanguinaria 10x, Sulphur 10x, Thuja occ. 10x, Echinacea 3x.
OTC - PURPOSE SECTION
Formulated for symptoms associated with colds and infections. Begin at the onset of symptoms.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Gluten-free, non-GMO, beet-derived sucrose pellets.
QUESTIONS SECTION
www.newtonlabs.net Newton Laboratories, Inc. FDA Est # 1051203 - Conyers, GA 30012
Questions? 1.800.448.7256
WARNINGS SECTION
Warning: Do not use if tamper - evident seal is broken or missing. Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days. Keep out of reach of children.
OTC - PREGNANCY OR BREAST FEEDING SECTION
Consult a licensed healthcare professional if pregnant, nursing or if symptoms worsen or persist for more than a few days.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
PACKAGE LABEL
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55714-1114-0 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5764-f424-e053-dadaa90a57ce | Sick Stopper |
| 55714-1114-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5764-f424-e053-dadaa90a57ce | Sick Stopper |
| 55714-1114-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-5764-f424-e053-dadaa90a57ce | Sick Stopper |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55714-1114 | SICK STOPPER (ANTHRACINUM, INFLUENZA A VIRUS, INFLUENZA B VIRUS, PYROGENIUM, BUFO RANA, ACONITUM NAP., AGARICUS MUSC., ARALIA QUINQUEFOLIA, BAPTISIA, BRYONIA, CHELIDONIUM MAJUS, EUPATORIUM PERF., HEPAR SULPH. CALC., LACHESIS, LYCOPODIUM, NUX VOM., RHUS TOXICODENDRON, SANGUINARIA, SULPHUR, THUJA OCC., ECHINACEA) PELLET [NEWTON LABORATORIES, INC.] | 1 | Legacy NDC | 20131018_6b12b072-1d0e-17c7-dbe4-b2b294e14aca.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| Amanita Muscaria Var. Muscaria Fruiting Body | ACTIVE INGREDIENT | DIF093I037 | 1 | |
| American Ginseng | ACTIVE INGREDIENT | 8W75VCV53Q | 1 | |
| Bacillus Anthracis Immunoserum Rabbit | ACTIVE INGREDIENT | 41LZ22DD4N | 1 | |
| Baptisia Tinctoria | ACTIVE INGREDIENT | 5K1UO2888Y | 1 | |
| Bryonia Alba Root | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| Bufo Bufo Cutaneous Gland | ACTIVE INGREDIENT | Q59QU6N72Q | 1 | |
| Calcium Sulfide | ACTIVE INGREDIENT | 1MBW07J51Q | 1 | |
| Chelidonium Majus | ACTIVE INGREDIENT | 7E889U5RNN | 1 | |
| Echinacea, Unspecified | ACTIVE INGREDIENT | 4N9P6CC1DX | 1 | |
| Eupatorium Perfoliatum Flowering Top | ACTIVE INGREDIENT | 1W0775VX6E | 1 | |
| Influenza A Virus | ACTIVE INGREDIENT | R9HH0NDE2E | 1 | |
| Influenza B Virus | ACTIVE INGREDIENT | 1314JZ2X6W | 1 | |
| Lachesis Muta Venom | ACTIVE INGREDIENT | VSW71SS07I | 1 | |
| Lycopodium Clavatum Spore | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| Rancid Beef | ACTIVE INGREDIENT | 29SUH5R3HU | 1 | |
| Sanguinaria Canadensis Root | ACTIVE INGREDIENT | N9288CD508 | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| Sulfur | ACTIVE INGREDIENT | 70FD1KFU70 | 1 | |
| Thuja Occidentalis Leafy Twig | ACTIVE INGREDIENT | 1NT28V9397 | 1 | |
| Toxicodendron Pubescens Leaf | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| Amanita Muscaria Var. Muscaria Fruiting Body | ACTIVE MOIETY | DIF093I037 | 1 | |
| American Ginseng | ACTIVE MOIETY | 8W75VCV53Q | 1 | |
| Bacillus Anthracis Immunoserum Rabbit | ACTIVE MOIETY | 41LZ22DD4N | 1 | |
| Baptisia Tinctoria | ACTIVE MOIETY | 5K1UO2888Y | 1 | |
| Bryonia Alba Root | ACTIVE MOIETY | T7J046YI2B | 1 | |
| Bufo Bufo Cutaneous Gland | ACTIVE MOIETY | Q59QU6N72Q | 1 | |
| Calcium Sulfide | ACTIVE MOIETY | 1MBW07J51Q | 1 | |
| Chelidonium Majus | ACTIVE MOIETY | 7E889U5RNN | 1 | |
| Echinacea, Unspecified | ACTIVE MOIETY | 4N9P6CC1DX | 1 | |
| Eupatorium Perfoliatum Flowering Top | ACTIVE MOIETY | 1W0775VX6E | 1 | |
| Influenza A Virus | ACTIVE MOIETY | R9HH0NDE2E | 1 | |
| Influenza B Virus | ACTIVE MOIETY | 1314JZ2X6W | 1 | |
| Lachesis Muta Venom | ACTIVE MOIETY | VSW71SS07I | 1 | |
| Lycopodium Clavatum Spore | ACTIVE MOIETY | C88X29Y479 | 1 | |
| Rancid Beef | ACTIVE MOIETY | 29SUH5R3HU | 1 | |
| Sanguinaria Canadensis Root | ACTIVE MOIETY | N9288CD508 | 1 | |
| Strychnos Nux-vomica Seed | ACTIVE MOIETY | 269XH13919 | 1 | |
| Sulfur | ACTIVE MOIETY | 70FD1KFU70 | 1 | |
| Thuja Occidentalis Leafy Twig | ACTIVE MOIETY | 1NT28V9397 | 1 | |
| Toxicodendron Pubescens Leaf | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| Sucrose | INACTIVE INGREDIENT | C151H8M554 | 1 |
Products#
Every source-derived product name is available through these pages.
- Sick Stopper
- Anthracinum, Influenza A Virus, Influenza B Virus, Pyrogenium, Bufo rana, Aconitum nap., Agaricus musc., Aralia quinquefolia, Baptisia, Bryonia, Chelidonium majus, Eupatorium perf., Hepar sulph. calc., Lachesis, Lycopodium, Nux vom., Rhus toxicodendron, Sanguinaria, Sulphur, Thuja occ., Echinacea
- Bacillus Anthracis Immunoserum Rabbit
- Influenza A Virus
- Rancid Beef
- Bufo Bufo Cutaneous Gland
- Aconitum Napellus
- Amanita Muscaria Var. Muscaria Fruiting Body
- American Ginseng
- Baptisia Tinctoria
- Bryonia Alba Root
- Chelidonium Majus
- Eupatorium Perfoliatum Flowering Top
- Calcium Sulfide
- Lachesis Muta Venom
- Lycopodium Clavatum Spore
- Strychnos Nux-vomica Seed
- Toxicodendron Pubescens Leaf
- Sanguinaria Canadensis Root
- Sulfur
- Thuja Occidentalis Leafy Twig
- Echinacea, Unspecified
- Influenza B Virus
- Sucrose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55714-1114 | 55714-1114-1, 55714-1114-2, 55714-1114-0 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CONCENTRATE / ORAL | 4800 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION/ DROPS / ORAL | 3750 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SOLUTION / ORAL | 38666 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / SUBCUTANEOUS | 47.75 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| Sucrose | SUCROSE | C151H8M554 | PASTILLE / ORAL | 426 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED PELLETS / ORAL | 59.8 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / ORAL | 70000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 119.12 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| Sucrose | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / ORAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, EMULSION / INTRAVENOUS | 970 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / BUCCAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / SUBLINGUAL | 109 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, EXTENDED RELEASE / ORAL | 619 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, CHEWABLE / ORAL | 7258 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| Sucrose | SUCROSE | C151H8M554 | ELIXIR / ORAL | 18000 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| Sucrose | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 900 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, COATED / ORAL | 516.42 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SOLUTION / ORAL | 42596 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, LIPOSOMAL / INTRAVENOUS | 9.4 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | SOLUTION / RECTAL | 35.42 %w/v | ||
| Sucrose | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| Sucrose | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| Sucrose | SUCROSE | C151H8M554 | CAPSULE, DELAYED RELEASE / ORAL | 955 mg | ||
| Sucrose | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| Sucrose | SUCROSE | C151H8M554 | TABLET, EXTENDED RELEASE / ORAL | 284.54 mg | ||
| Sucrose | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 40819069-1bce-5116-e063-6394a90afd3c | 6b12b072-1d0e-17c7-dbe4-b2b294e14aca | 2025-10-06 | Warnings | 6b12b072-1d0e-17c7-dbe4-b2b294e14aca |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
